A 12 Week Double-blind, Randomized, Placebo-controlled Trial to Investigate Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets at Doses of 50 and 70 mg Administered Twice a Day in Patients With Active Rheumatoid Arthritis Who Have Failed at Least One DMARD
Latest Information Update: 06 Nov 2021
Price :
$35 *
At a glance
- Drugs Doramapimod (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 19 Aug 2014 New trial record